Cargando…

Suppression of triple-negative breast cancer aggressiveness by LGALS3BP via inhibition of the TNF-α–TAK1–MMP9 axis

Transforming growth factor-β-activated kinase 1 (TAK1), which is highly expressed and aberrantly activated in triple-negative breast cancer (TNBC), plays a pivotal role in metastasis and progression. This makes it a potential therapeutic target for TNBC. Previously, we reported lectin galactoside-bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Eun-Gene, Vijayan, Veena, Park, Mi-Ra, Yoo, Kyung Hyun, Cho, Sang-Hee, Bae, Woo-Kyun, Shim, Hyun-Jeong, Hwang, Jun-Eul, Park, In-Kyu, Chung, Ik-Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090165/ https://www.ncbi.nlm.nih.gov/pubmed/37041137 http://dx.doi.org/10.1038/s41420-023-01419-9

Ejemplares similares

Lgals3bp suppresses colon inflammation and tumorigenesis through the downregulation of TAK1-NF-κB signaling
por: Cho, Sang-Hee, et al.
Publicado: (2021)

Gal-3BP Negatively Regulates NF-κB Signaling by Inhibiting the Activation of TAK1
por: Hong, Chang-Soo, et al.
Publicado: (2019)

Prognostic relevance of LGALS3BP in human colorectal carcinoma
por: Piccolo, Enza, et al.
Publicado: (2015)

Circulating Autoantibodies to LGALS3BP: A Novel Biomarker for Cancer
por: Grassadonia, Antonino, et al.
Publicado: (2013)

The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific
por: Lodermeyer, Veronika, et al.
Publicado: (2018)

Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
por: Capone, Emily, et al.
Publicado: (2020)

Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases
por: Costa, Júlia, et al.
Publicado: (2020)

Extracellular LGALS3BP regulates neural progenitor position and relates to human cortical complexity
por: Kyrousi, Christina, et al.
Publicado: (2021)

LGALS3BP: A Potential Plasma Biomarker Associated with Diagnosis and Prognosis in Patients with Sepsis
por: Luo, Meiyan, et al.
Publicado: (2021)

Suppressive Effect of 19-nor-1α-25-Dihydroxyvitamin D2 on Gastric Cancer Cells and Peritoneal Metastasis Model
por: Park, Mi Ra, et al.
Publicado: (2012)

LGALS3BP in Microglia Promotes Retinal Angiogenesis Through PI3K/AKT Pathway During Hypoxia
por: Zhao, Chenyang, et al.
Publicado: (2022)

Extracellular LGALS3BP: a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma
por: Dufrusine, Beatrice, et al.
Publicado: (2023)

Blockade of VEGFR-1 and VEGFR-2 Enhances Paclitaxel Sensitivity in Gastric Cancer Cells
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

90K/LGALS3BP expression is upregulated in COVID-19 but may not restrict SARS-CoV-2 infection
por: Bosquillon de Jarcy, Laure, et al.
Publicado: (2023)

In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer
por: Ji, Peng, et al.
Publicado: (2022)

Complete biologic response to taxane based chemotherapy confirmed by [(18)F]FDG PET/CT and surgery in a cancer of unknown primary site
por: Hwang, Jun-Eul, et al.
Publicado: (2012)

Benefits of Adjuvant Chemotherapy for Clinical T3-4N0 Rectal Cancer After Preoperative Chemoradiotherapy
por: Bang, Hyun Jin, et al.
Publicado: (2023)

Inducible LGALS3BP/90K activates antiviral innate immune responses by targeting TRAF6 and TRAF3 complex
por: Xu, Gang, et al.
Publicado: (2019)

Validation of Salivary Markers, IL-1β, IL-8 and Lgals3bp for Detection of Oral Squamous Cell Carcinoma in an Indian Population
por: Singh, Prerana, et al.
Publicado: (2020)

Upregulation of LGALS1 is associated with oral cancer metastasis
por: Li, Ji-Min, et al.
Publicado: (2018)

Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor
por: Hwang, Jun-Eul, et al.
Publicado: (2010)

Geriatric functional assessment for decision-making on adjuvant chemotherapy in older colon cancer patients
por: Bang, Hyun Jin, et al.
Publicado: (2022)

Intravenous KITENIN shRNA Injection Suppresses Hepatic Metastasis and Recurrence of Colon Cancer in an Orthotopic Mouse Model
por: Hwang, Jun-Eul, et al.
Publicado: (2011)

TAK228 enhances antitumor activity of eribulin in triple negative breast cancer
por: Owusu-Brackett, Nicci, et al.
Publicado: (2019)

Reversible Proximal Renal Tubular Dysfunction after One-Time Ifosfamide Exposure
por: Kim, Young Il, et al.
Publicado: (2010)

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1
por: Si, Wentao, et al.
Publicado: (2022)

SREBP1 regulates Lgals3 activation in response to cholesterol loading
por: Li, Jing, et al.
Publicado: (2022)

LGALS1 regulates cell adhesion to promote the progression of ovarian cancer
por: Li, Xuejian, et al.
Publicado: (2023)

Circular RNA circARHGEF28 inhibited the progression of prostate cancer via the miR‐671‐5p/LGALS3BP/NF‐κB axis
por: Guo, Kaixuan, et al.
Publicado: (2023)

TAK1 kinase switches cell fate from apoptosis to necrosis following TNF stimulation
por: Morioka, Sho, et al.
Publicado: (2014)

Deficiency of PPP6C protects TNF-induced necroptosis through activation of TAK1
por: Zou, Yonggang, et al.
Publicado: (2022)

Enhanced cortical bone expansion in Lgals3-deficient mice during aging
por: Maupin, Kevin A., et al.
Publicado: (2018)

Promoter hypermethylation of LGALS4 correlates with poor prognosis in patients with urothelial carcinoma
por: Wu, Meei-Maan, et al.
Publicado: (2017)

Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2
por: Nunoue, Tomokazu, et al.
Publicado: (2021)

A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)
por: Lv, Yan, et al.
Publicado: (2022)

The Prevalence of TNFα-Induced Necrosis over Apoptosis Is Determined by TAK1-RIP1 Interplay
por: Çöl Arslan, Seda, et al.
Publicado: (2011)

Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 Gastrectomy
por: Shim, Hyun-Jeong, et al.
Publicado: (2020)

Hepatic arterial infusion chemotherapy versus systemic therapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis
por: Kim, Hyeon-Jong, et al.
Publicado: (2023)

First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
por: HWANG, JUN-EUL, et al.
Publicado: (2012)

The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy
por: Shim, Hyun-Jeong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n4raqueti5t993cqs38n96kjk1